USPTO New Claims and Continuations Rules – Frequently Asked Questions
October 9, 2007
The new United States Patent and Trademark Office (USPTO) Claims and Continuations Rules have generated many questions from those who are actively involved in building intellectual property (IP) assets in the legal and corporate world. What follows are answers to client questions and those received during Foley’s Patent Nation Web Conference, “USPTO Director Jon Dudas and IP Professionals Discuss New USPTO Claims and Continuations Rules and Their Practical Implications.” The session was held on September 12, 2007. The responses include comments from:
- Jon W. Dudas, Under Secretary of Commerce for Intellectual Property, and Director of the USPTO
- Bob Bahr, Senior Patent Counsel, Office of the Deputy Commissioner for Patent Examination Policy, USPTO
- Courtenay Brinckerhoff, Steve Fox, Steve Maebius, Phil Kiko, and Simon Elliott, Foley
Read the complete article by clicking on the link below.
Author(s)
Related Insights
Watch On-Demand
Upcoming
Events
Get Anytime Access to Continuing Legal Education and Business Programming
Our new LearningLab: On-Demand Hub offers a growing library of continuing legal education (CLE) and business-focused legal insights you can now access anytime, anywhere.
November 6, 2026
Upcoming
Events
Medicare & Medicaid Administrative Enforcement: Emerging Trends
Foley partner Judy Waltz, chair of the Health Care Practice Group, is speaking in the California Society for Healthcare Attorneys’ upcoming Fall Seminar in the session “Medicare & Medicaid Administrative Enforcement: Emerging Trends.”
November 6, 2026
Events
Election Results Are In: What the 2026 Midterm Election Results Mean for Congress, the Administration, and Your Business
The 2026 midterm elections will reset the political landscape — and organizations across industries will need to understand what comes next. Join Foley & Lardner for a timely post-election briefing that goes beyond the headlines to examine the results, the new balance of power in Congress, and the Trump Administration’s likely response.